Redcliffe Genetics

Noida, India Founded: 2017 • Age: 9 yrs Minicorn
Diagnostic services are provided to research, healthcare, and industry partners.

About Redcliffe Genetics

Redcliffe Genetics is a Healthcare company based in Noida (India) founded in 2017 by Ashish Dubey, Dheeraj Jain, and Aditya Kandoi. Diagnostic services are provided to research, healthcare, and industry partners. Redcliffe Genetics has raised $63.21 million across 5 funding rounds from investors including LeapFrog Investments, Schroders and HealthQuad. The company has 2,104 employees. Redcliffe Genetics was last valued at $1.82 million in February 2021. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service.

Company details

Redcliffe Genetics was established in 2017 in Noida, India, within the genetics and diagnostics sector. Products and services are delivered to research institutions, healthcare providers, and industry collaborators. High-throughput platforms, including MGI DNB-Seq and nanostring technologies, are integrated for sequencing applications. Offerings include whole genome sequencing, exome sequencing, amplicon sequencing, and molecular diagnostics targeting cytogenetics, rare genetic disorders, and infertility.

  • Headquarters Noida, India
  • Employees 2,104
  • Founders Ashish Dubey, Dheeraj Jain, Aditya Kandoi
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website redcliffegenetics.com
  • Social LinkedIn X Facebook
Key Metrics
  • Annual Revenue
    $210.35 K (USD)
    -78
    as on Mar 31, 2024
  • Net Profit
    -$1.31 M (USD)
    -14
    as on Mar 31, 2024
  • EBITDA
    -$1.31 M (USD)
    -16
    as on Mar 31, 2024
  • Total Equity Funding
    $63.21M (USD)

    in 5 rounds

  • Latest Funding Round
    $61M (USD), Series B

    May 2022

  • Investors
  • Employee Count
    2,104

Funding Insights of Redcliffe Genetics

Redcliffe Genetics has successfully raised a total of $63.21M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $61 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $63.21M
  • Total Rounds 5
  • Last Round Series B β€” $61M
  • First Round $690,627

    (Dec 2017)

  • Investors Count 35

All 5 funding rounds of Redcliffe Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$61MSeries B–LeapFrog Investments
Feb 2021$536,061Seed$1.82MIDG Ventures
Jan 2020$632,700Seed$6.33MJai Drinks
May 2019$354,198Angel Round$β€’β€’β€’β€’β€’Muralidhar Odhrani, Rakesh Kumar Maurya
Dec 2017$690,627Seed$β€’β€’β€’β€’β€’ALFA Ventures
Valuation history
DateValuationStage
Feb 2021$1.82Mβ€’β€’β€’β€’β€’β€’β€’β€’
Jan 2020$6.33Mβ€’β€’β€’β€’β€’β€’β€’β€’
May 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Dec 2017$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Redcliffe Genetics

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $1.82M (Feb 2021). 35 investors in total: 14 institutional and 21 angel.

Investors in Redcliffe Genetics

Redcliffe Genetics has secured backing from 35 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LeapFrog Investments, Schroders and HealthQuad.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Private equity fund focused on banking, finance, healthcare, and multiple sectors
2007leapfroginvest.comJohannesburg, South Africa
Healthcare investment fund focused on innovation and social impact in India.
2016healthquad.inDelhi, India
Seed-stage tech-focused VCl firm investing primarily in the US
nuevaventures.comSan Mateo, United States
Early-stage tech startups are invested in by Spark Growth Ventures.
sparkgv.comSan Diego, United States
Venture capital fund focused on seed-stage startups
chiratae.comBengaluru, India
Investment in early-stage healthcare companies for consumer well-being and growth.
2017alkemivp.comDelhi, India
Tech focused Venture Capital firm investing globally
idgventures.comSan Francisco, United States
Diversified operations in beverages, real estate, manufacturing, IT, and education across India.
2010jaipuria.coDelhi, India
Stage-agnostic tech-focused VC firm funding companies in India
2017greenshootscapital.co.inMumbai, India
Investment management and wealth management services are provided to clients.
1804schroders.comLondon, United Kingdom
Premium access

Investor details for Redcliffe Genetics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Redcliffe Genetics

The boards of the 4 registered companies of Redcliffe Genetics currently have 8 directors; the longest-serving is Vikas Bagaria, appointed in 2017. 28 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vikas Bagaria
DIN 00064405
Director05 Apr 20179 yrs 7 moRedcliffe Hygiene Private Limited
Dhiraj Jain
DIN 07124088
Director01 Sep 20179 yrs 2 moRedcliffe Lifescience Private Limited, Redcliffe Life Images Private Limited, Redcliffe Lifetech Private Limited
Rithish Kumar
DIN 10098002
Director31 Mar 20233 yrs 7 moRedcliffe Hygiene Private Limited
Radhika Bagla
DIN 09649563
Director01 Aug 20233 yrs 3 moRedcliffe Lifescience Private Limited, Redcliffe Life Images Private Limited, Redcliffe Lifetech Private Limited
Aditya Kandoi
DIN 01060948
Director30 Mar 20242 yrs 7 moRedcliffe Lifescience Private Limited, Redcliffe Life Images Private Limited, Redcliffe Lifetech Private Limited
Rohit Jalan
DIN 10373301
Director30 Mar 20242 yrs 7 moRedcliffe Lifescience Private Limited, Redcliffe Life Images Private Limited, Redcliffe Lifetech Private Limited
Sumona Chakraborty
DIN 09597426
Nominee Director27 Jan 20269 moRedcliffe Hygiene Private Limited
Sunny Sharma
DIN 02267273
Nominee Director27 Jan 20269 moRedcliffe Hygiene Private Limited

People of Redcliffe Genetics

3 people are tracked at Redcliffe Genetics (3 in leadership); the tracked headcount is 2,104.

NameRoleGroup
Ashish Dubey
Co-FounderLeadership
Dheeraj Jain
Co-FounderLeadership
Co-FounderLeadership
Premium access

Complete people profiles for Redcliffe Genetics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Redcliffe Genetics

Figures of Redcliffe Hygiene Private Limited, the primary company behind Redcliffe Genetics, for FY 2025. Revenue was ₹82.58 Cr (+44% year on year). Net loss was -₹4.05 Cr (-5% margin). EBITDA was -₹5.68 Cr (-7% margin). Revenue has grown at a compounded annual rate of +27% over three years and +35% over five years.

  • ₹82.58 CrRevenue · FY 2025 · +44% YoY
  • -₹4.05 CrNet loss · -5% margin
  • -₹5.68 CrEBITDA · -7% margin
  • ₹43.4 LakhPaid-up capital
  • 116Employees (provident fund records)
  • +27%Revenue CAGR, 3 years
  • +35%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Redcliffe Hygiene Private Limited are on its company page.

Premium access

Detailed financial statements for Redcliffe Genetics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Redcliffe Genetics

4 dated milestones of Redcliffe Genetics across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Redcliffe Genetics is founded.
  2. Funding First funding round of $691K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $61.0M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Redcliffe Genetics

Premium access

Complete news archive for Redcliffe Genetics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Redcliffe Genetics

Redcliffe Genetics was founded in 2017.

Redcliffe Genetics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

Redcliffe Genetics is a funded company, having raised a total of $63.21M across 5 funding rounds to date. The company's 1st funding round was a Seed of $690.63K, raised on Dec 2017.

Redcliffe Genetics has 2,104 employees.

Annual revenue of Redcliffe Genetics is $210.35K as on Mar 31, 2024.

Redcliffe Genetics was established in 2017 in Noida, India, within the genetics and diagnostics sector. Products and services are delivered to research institutions, healthcare providers, and industry collaborators. High-throughput platforms, including MGI DNB-Seq and nanostring technologies, are integrated for sequencing applications. Offerings include whole genome sequencing, exome sequencing, amplicon sequencing, and molecular diagnostics targeting cytogenetics, rare genetic disorders, and infertility.

Redcliffe Genetics has 35 investors. Key investors include LeapFrog Investments, Schroders, HealthQuad, Alkemi Partners, and Jaipuria Group.

The valuation of Redcliffe Genetics is $1.82M as of Feb 2021.

Redcliffe Genetics is associated with 4 legal entities: Redcliffe Hygiene Private Limited, Redcliffe Lifescience Private Limited, Redcliffe Life Images Private Limited and others.

The legal entities of Redcliffe Genetics currently have 8 directors, including Vikas Bagaria, Rithish Kumar, Sumona Chakraborty and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available